Breast Cancer Clinical Trials in Houston, TX

Breast Cancer Clinical Trials in Houston, TX

View the best 10 breast cancer medical studies in Houston, Texas. Access promising new therapies by applying to a Houston-based Breast Cancer clinical trial.

Trials in Houston, Texas

Here are the top 10 medical studies for breast cancer in Houston, Texas

Image of Research Site in Whittier, United States.

Placebo +2 More

Chemotherapy

Recruiting1 awardPhase 3
This trial is testing a new combination of drugs to treat TNBC compared to the current standard of care.
Image of St. Joseph's Hospital and Medical Center in Phoenix, United States.

Fulvestrant +1 More

Estrogen Receptor Antagonist

Recruiting1 awardPhase 3
This trial is testing a combination of two drugs, abemaciclib and fulvestrant, for treating a specific type of breast cancer that has not responded to previous treatments. Abemaciclib is taken orally and is approved for treating certain types of breast cancer. The goal is to see if this combination can help stop the cancer from growing. The study may last several years, depending on how well the treatment works for each patient.
Image of Mayo Clinic in Scottsdale, United States.

CYT-0851

Small Molecule Inhibitor

Recruiting3 awardsPhase 1 & 2
This trial is testing a new drug called CYT-0851 in patients with certain types of cancer that have not responded to other treatments. The goal is to see if the drug is safe and understand how it works in the body.
Image of Northwest Georgia Oncology Centers PC - Marietta in Marietta, United States.

Giredestrant +2 More

Selective Estrogen Receptor Degrader (SERD)

Recruiting1 awardPhase 2
This trial is testing giredestrant, a new drug, to see if it works better than usual hormone treatments for certain breast cancer patients. It targets patients whose cancer grows with the help of estrogen and who have already tried other treatments. The drug aims to block a protein that helps the cancer grow.
Image of Research Site in Tucson, United States.

Trastuzumab Deruxtecan +2 More

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial will test a new cancer drug to see if it is effective and safe for patients with HER2-positive breast cancer.
Image of Northwestern Medicine Cancer Center in Warrenville, United States.

TOL2506

Hormone Therapy

Recruiting2 awardsPhase 3
This trial tests TOL2506, a treatment that stops ovaries from working, in premenopausal women and men with hormone-sensitive breast cancer. It aims to reduce hormone levels to slow down or stop cancer growth. TOL2506 is a treatment that stops ovaries from working, similar to other ovarian suppression methods.
Image of Pacific Cancer Care ( Site 0142) in Monterey, United States.

Pembrolizumab +1 More

Immune Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial is comparing the efficacy of two different treatments for triple negative breast cancer - olaparib plus pembrolizumab versus chemotherapy plus pembrolizumab. The primary hypotheses are that olaparib plus pembrolizumab will be superior to chemotherapy plus pembrolizumab in terms of progression-free survival and overall survival.
Image of Mayo Clinic Hospital in Arizona in Phoenix, United States.

Radiation Therapy

Radiation

Recruiting1 awardPhase 1
This trial studies the best dose of berzosertib combined with radiation therapy for treating certain types of breast cancer. Berzosertib helps stop cancer cell growth by blocking important enzymes, while radiation kills the cancer cells. This combination may work better than radiation alone.
Image of Wake Forest School of Medicine in Winston-Salem, United States.

Control arm

Recruiting1 award11 criteria
This trial is testing if letting people choose which health questionnaire to fill out leads to more people filling it out and if they find it more acceptable.
Image of Epic Care-Dublin in Dublin, United States.

Sacituzumab Govitecan

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial is studying sacituzumab govitecan to see how well it works in treating patients with HER2-negative breast cancer that has spread to the brain.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.